Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses.
about
Construction of a novel cell-based assay for the evaluation of anti-EGFR drug efficacy against EGFR mutation.Continued EGFR-TKI with concurrent radiotherapy to improve time to progression (TTP) in patients with locally progressive non-small cell lung cancer (NSCLC) after front-line EGFR-TKI treatment.Characterization of In Vivo Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance.
P2860
Non-small-cell lung cancer cells combat epidermal growth factor receptor tyrosine kinase inhibition through immediate adhesion-related responses.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Non-small-cell lung cancer cel ...... te adhesion-related responses.
@en
type
label
Non-small-cell lung cancer cel ...... te adhesion-related responses.
@en
prefLabel
Non-small-cell lung cancer cel ...... te adhesion-related responses.
@en
P2093
P2860
P356
P1476
Non-small-cell lung cancer cel ...... te adhesion-related responses.
@en
P2093
Ching-Ping Tseng
Feng-Chi Chen
Hsian-Yu Wang
John T-A Hsu
Kai-Hsuan Wang
Min-Kung Hsu
P2860
P304
P356
10.2147/OTT.S96341
P407
P577
2016-05-19T00:00:00Z